Chen Yiru, Qi Weikun, Wang Zhenghao, Niu Feng
Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 33 Badachu Road, Shijingshan, Beijing 100144, China.
Pharmaceutics. 2025 Jan 22;17(2):147. doi: 10.3390/pharmaceutics17020147.
Exosomes have emerged as promising therapeutic agents in regenerative medicine. This review introduces a novel cell type-oriented perspective to systematically analyze exosomal properties in regenerative therapies. To our knowledge, this review is the first to comprehensively compare exosomes based on cellular source type, offering unprecedented insights into selecting optimal exosome producers for targeted regenerative applications. Factors beyond cellular origin influencing exosomal therapeutic efficacy, such as donor sites and collection methods, are also explored here. By synthesizing key advances, we propose promising research directions in the end. We aim to accelerate the development of more effective exosome-based regenerative therapies and highlight underexplored directions in this rapidly evolving field.
外泌体已成为再生医学中颇具前景的治疗剂。本综述引入了一种新颖的面向细胞类型的视角,以系统地分析再生疗法中外泌体的特性。据我们所知,本综述首次基于细胞来源类型对外泌体进行了全面比较,为选择用于靶向再生应用的最佳外泌体产生细胞提供了前所未有的见解。本文还探讨了细胞来源以外影响外泌体治疗效果的因素,如供体部位和收集方法。通过综合关键进展,我们最后提出了有前景的研究方向。我们旨在加速更有效的基于外泌体的再生疗法的开发,并突出这一快速发展领域中未充分探索的方向。
Pharmaceutics. 2025-1-22
Funct Integr Genomics. 2024-7-12
Gels. 2024-11-23
Tissue Eng Regen Med. 2025-1-20
Adv Wound Care (New Rochelle). 2024-11
Cancers (Basel). 2023-3-27
Biomed Pharmacother. 2023-12-31
World J Stem Cells. 2025-7-26
World J Stem Cells. 2025-5-26
Stem Cell Res Ther. 2024-12-29
Biochim Biophys Acta Gen Subj. 2025-2
Front Endocrinol (Lausanne). 2024
Colloids Surf B Biointerfaces. 2024-12
J Nanobiotechnology. 2024-8-30